These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 31015296)

  • 21. Cortical β-amyloid burden, gray matter, and memory in adults at varying APOE ε4 risk for Alzheimer's disease.
    Mecca AP; Barcelos NM; Wang S; Brück A; Nabulsi N; Planeta-Wilson B; Nadelmann J; Benincasa AL; Ropchan J; Huang Y; Gelernter J; Van Ness PH; Carson RE; van Dyck CH
    Neurobiol Aging; 2018 Jan; 61():207-214. PubMed ID: 29111487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive impairment in Alzheimer's disease is modified by APOE genotype.
    van der Vlies AE; Pijnenburg YA; Koene T; Klein M; Kok A; Scheltens P; van der Flier WM
    Dement Geriatr Cogn Disord; 2007; 24(2):98-103. PubMed ID: 17596691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of TOMM40 on spatial navigation in amnestic mild cognitive impairment.
    Laczó J; Andel R; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Lerch O; Gazova I; Moffat SD; Hort J
    Neurobiol Aging; 2015 Jun; 36(6):2024-33. PubMed ID: 25862420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Application of APOE in Alzheimer's Prevention: A Precision Medicine Approach.
    Berkowitz CL; Mosconi L; Rahman A; Scheyer O; Hristov H; Isaacson RS
    J Prev Alzheimers Dis; 2018; 5(4):245-252. PubMed ID: 30298183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple Effect of APOE Genotype on Clinical and Neuroimaging Biomarkers Across Alzheimer's Disease Spectrum.
    Liu Y; Tan L; Wang HF; Liu Y; Hao XK; Tan CC; Jiang T; Liu B; Zhang DQ; Yu JT;
    Mol Neurobiol; 2016 Sep; 53(7):4539-47. PubMed ID: 26298664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease.
    Chang YL; Fennema-Notestine C; Holland D; McEvoy LK; Stricker NH; Salmon DP; Dale AM; Bondi MW;
    Alzheimers Dement; 2014 May; 10(3):336-48. PubMed ID: 23896613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.
    Hsiung GY; Sadovnick AD; Feldman H
    CMAJ; 2004 Oct; 171(8):863-7. PubMed ID: 15477624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. APOE ε4 moderates amyloid-related memory decline in preclinical Alzheimer's disease.
    Lim YY; Villemagne VL; Pietrzak RH; Ames D; Ellis KA; Harrington K; Snyder PJ; Martins RN; Masters CL; Rowe CC; Maruff P;
    Neurobiol Aging; 2015 Mar; 36(3):1239-44. PubMed ID: 25559335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does an Alzheimer's disease susceptibility gene influence the cognitive effects of cancer therapy?
    Caselli RJ
    Pediatr Blood Cancer; 2014 Oct; 61(10):1739-42. PubMed ID: 24106134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.
    Wishart HA; Saykin AJ; Rabin LA; Santulli RB; Flashman LA; Guerin SJ; Mamourian AC; Belloni DR; Rhodes CH; McAllister TW
    Am J Psychiatry; 2006 Sep; 163(9):1603-10. PubMed ID: 16946187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apolipoprotein E epsilon4, Alzheimer's disease, and cognitive performance in elderly Mexican Mestizos.
    Villalpando-Berumen JM; Mejia-Arango S; Aguilar-Salinas CA; Ordonez-Sanchez ML; Gutierrez-Robledo LM
    J Am Geriatr Soc; 2008 Apr; 56(4):677-82. PubMed ID: 18205760
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.
    El Haj M; Antoine P; Amouyel P; Lambert JC; Pasquier F; Kapogiannis D
    Ageing Res Rev; 2016 May; 27():15-22. PubMed ID: 26876367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition memory is associated with altered resting-state functional connectivity in people at genetic risk for Alzheimer's disease.
    Matura S; Prvulovic D; Butz M; Hartmann D; Sepanski B; Linnemann K; Oertel-Knöchel V; Karakaya T; Fußer F; Pantel J; van de Ven V
    Eur J Neurosci; 2014 Oct; 40(7):3128-35. PubMed ID: 24989884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision tree analysis of genetic risk for clinically heterogeneous Alzheimer's disease.
    Yokoyama JS; Bonham LW; Sears RL; Klein E; Karydas A; Kramer JH; Miller BL; Coppola G
    BMC Neurol; 2015 Mar; 15():47. PubMed ID: 25880661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aging, Practice Effects, and Genetic Risk in the Wisconsin Registry for Alzheimer's Prevention.
    Jonaitis EM; Koscik RL; La Rue A; Johnson SC; Hermann BP; Sager MA
    Clin Neuropsychol; 2015; 29(4):426-41. PubMed ID: 26012360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE-ε4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Saeed U; Mirza SS; MacIntosh BJ; Herrmann N; Keith J; Ramirez J; Nestor SM; Yu Q; Knight J; Swardfager W; Potkin SG; Rogaeva E; St George-Hyslop P; Black SE; Masellis M
    Alzheimers Dement; 2018 Sep; 14(9):1137-1147. PubMed ID: 29782824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced hippocampal volume in non-demented carriers of the apolipoprotein E epsilon4: relation to chronological age and recognition memory.
    Lind J; Larsson A; Persson J; Ingvar M; Nilsson LG; Bäckman L; Adolfsson R; Cruts M; Sleegers K; Van Broeckhoven C; Nyberg L
    Neurosci Lett; 2006 Mar; 396(1):23-7. PubMed ID: 16406347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of APOE-ε4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Cacciaglia R; Molinuevo JL; Falcón C; Brugulat-Serrat A; Sánchez-Benavides G; Gramunt N; Esteller M; Morán S; Minguillón C; Fauria K; Gispert JD;
    Alzheimers Dement; 2018 Jul; 14(7):902-912. PubMed ID: 29605385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.
    Juottonen K; Lehtovirta M; Helisalmi S; Riekkinen PJ; Soininen H
    J Neurol Neurosurg Psychiatry; 1998 Sep; 65(3):322-7. PubMed ID: 9728943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.